New corporate development head at Mundipharma

pharmafield logo - pharma news

 European pharmaceutical group Mundipharma has appointed Paul Medeiros as Head of Corporate and Business Development.

Medeiros, who joins the group from AVI BioPharma, will join the executive leadership team and be responsible for extending and expanding areas for growth.

Based in the UK, Mundipharma is a network of companies across 32 European countries, including Napp in the UK.

Medeiros was previously Senior VP and Chief Business Officer at AVI BioPharma, a specialist in RNA-based drugs for rare diseases.

Over 19 years in the biopharmaceutical industry, Medeiros has also been VP of Global Licensing and Strategic Alliances for Schering-Plough and held several roles in sales and marketing at Merck & Co.

His experience includes licensing and strategic partnering initiatives in specialist therapy areas.

Antony Mattessich, Regional Director, Mundipharma Europe, said: “Paul’s deep experience and network in the pharma industry, combined with his entrepreneurial mind-set and nuanced understanding of the business, will be essential for Mundipharma’s continued growth.”